LeMay, D R <br/><br/>
Intravenous RMP-7 increases delivery of ganciclovir into rat brain tumors and enhances the effects of herpes simplex virus thymidine kinase gene therapy.  [electronic resource] 

 -  Human gene therapy  May 1998 
 - 989-95 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1043-0342 
<br/><br/><label>Standard No.: </label>10.1089/hum.1998.9.7-989  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>3T3 Cells<br/>Animals<br/>Antiviral Agents--pharmacology<br/>Blood-Brain Barrier<br/>Bradykinin--analogs & derivatives<br/>Brain Neoplasms--therapy<br/>Cell Division--drug effects<br/>Drug Synergism<br/>Ganciclovir--pharmacology<br/>Genetic Therapy<br/>Glioma--therapy<br/>Infusions, Intravenous<br/>Mice<br/>Neoplasms, Experimental<br/>Rats<br/>Rats, Sprague-Dawley<br/>Simplexvirus--enzymology<br/>Thymidine Kinase--genetics<br/>Tumor Cells, Cultured